Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SULT1A1 modulators(sulfotransferase family 1A member 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Preclinical | US | 04 Apr 2023 |